FUS and myxoid liposarcoma: Myxoid liposarcoma harbors FUS/EWSR1-DDIT3 fusions, and nuclear DNA damage-inducible transcript 3 (DDIT3) immunoreactivity is a highly sensitive and specific marker [9].